Marc S. Sherman

845 total citations
18 papers, 648 citations indexed

About

Marc S. Sherman is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Marc S. Sherman has authored 18 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Hepatology and 5 papers in Epidemiology. Recurrent topics in Marc S. Sherman's work include Liver Disease Diagnosis and Treatment (4 papers), Gene Regulatory Network Analysis (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Marc S. Sherman is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Gene Regulatory Network Analysis (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Marc S. Sherman collaborates with scholars based in United States, Poland and Canada. Marc S. Sherman's co-authors include Kevin Truong, Mitsuhiko Ikura, Tao Yuan, Kyoko L. Yap, Justin Kim, Barak A. Cohen, Kimberly Lorenz, M. Hunter Lanier, Tara M. Riddle and Robi D. Mitra and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Marc S. Sherman

17 papers receiving 637 citations

Peers

Countries citing papers authored by Marc S. Sherman

Since Specialization

Citations

This map shows the geographic impact of Marc S. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc S. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc S. Sherman more than expected).

Fields of papers citing papers by Marc S. Sherman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc S. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc S. Sherman. The network helps show where Marc S. Sherman may publish in the future.

Co-authorship network of co-authors of Marc S. Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Marc S. Sherman. A scholar is included among the top collaborators of Marc S. Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc S. Sherman. Marc S. Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Expression of DNAJB1-PRKACA oncogene suppresses the differentiation potential of liver progenitor organoids towards a hepatocyte lineage 2025 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Marc S. Sherman, Qianyi Ma, Liang Sun, (unknown), (unknown), Ina Kycia, Praveen Sethupathy, Wolfram Goessling, Michael S. Rogers, Khashayar Vakili	1
2	A natural language processing algorithm accurately classifies steatotic liver disease pathology to estimate the risk of cirrhosis 2024 ·Hepatology Communications ·Marc S. Sherman, (unknown), Eric M. Przybyszewski, Robert M. Wilechansky, (unknown), (unknown), (unknown), Wolfram Goessling, Hamed Khalili, Tracey G. Simon	2
3	Discovery of biophysical rate laws from the electronic health record enables real-time liver injury estimation from transaminase dynamics 2024 ·Cell Reports Medicine ·Marc S. Sherman, Wolfram Goessling	1
4	SARS-CoV-2 viral liver aggregates and scarce parenchymal infection implicate systemic disease as a driver of abnormal liver function 2023 ·Hepatology Communications ·Brian J. Pepe-Mooney, Colton Smith, Marc S. Sherman, Trista E. North, Robert F. Padera, Wolfram Goessling	1
5	Tu1252: AN ENHANCED TOOLKIT FOR THE ALGORITHMIC DETECTION OF PATIENTS WITH AUTOIMMUNE HEPATITIS IN A MULTI-HOSPITAL HEALTHCARE SYSTEM 2022 ·Gastroenterology ·(unknown), Wolfram Goessling, Marc S. Sherman	1
6	Myelofibrosis and Portal Hypertension: The Case for Primary Variceal Screening 2020 ·ACG Case Reports Journal ·Marc S. Sherman, Wesley Samore, Daniel S. Pratt	4
7	Case 36-2019: A 34-Year-Old Man with Dyspnea, Odynophagia, and Abdominal Pain 2019 ·New England Journal of Medicine ·Michael S. Saag, Dexter P. Mendoza, Marc S. Sherman, Gregory A. Coté, Angela Shih	0
8	Ongoing complete remissions in phase 1 of ZUMA-1: a phase 1-2 multi-center study evaluating the safety and efficacy of KTE-C19 (anti-CD19 CAR T cells) in patients with refractory aggressive B cell non-Hodgkin lymphoma (NHL) 2016 ·Annals of Oncology ·Frederick L. Locke, Sattva S. Neelapu, Nancy L. Bartlett, Tanya Siddiqi, Julio C. Chávez, Chitra Hosing, Amanda F. Cashen, Lihua E. Budde, Marc S. Sherman, (unknown), Lynn Navale, Yuzhang Jiang, Jeff Aycock, Meg Elias, Jeff Wiezorek, William Y. Go	3
9	Cell-to-Cell Variability in the Propensity to Transcribe Explains Correlated Fluctuations in Gene Expression 2015 ·Cell Systems ·Marc S. Sherman, Kimberly Lorenz, M. Hunter Lanier, Barak A. Cohen	51
10	A Computational Framework for Analyzing Stochasticity in Gene Expression 2014 ·PLoS Computational Biology ·Marc S. Sherman, Barak A. Cohen	20
11	Origin and Consequences of the Relationship between Protein Mean and Variance 2014 ·PLoS ONE ·Francesco Vallania, Marc S. Sherman, (unknown), Ilaria Mogno, Barak A. Cohen, Robi D. Mitra	11
12	Thermodynamic State Ensemble Models of cis-Regulation 2012 ·PLoS Computational Biology ·Marc S. Sherman, Barak A. Cohen	60
13	699 OBSERVED PATTERNS OF SYSTEMIC THERAPY USE IN HEPATOCELLULAR CARCINOMA (HCC) PATIENTS FROM THE MULTINATIONAL HCC BRIDGE STUDY: RESULTS OF A SECOND INTERIM ANALYSIS 2012 ·Journal of Hepatology ·Massimo Colombo, Lewis R. Roberts, M. Schwartz, Françoise Degos, Marc S. Sherman, (unknown), (unknown), (unknown), Masatoshi Kudo, P. Johnson, Bing‐Shen Huang, (unknown), Lucinda Orsini	1
14	HCC BRIDGE study : BRIDGE to better outcomes in hepatocellular carcinoma 2009 ·Marc S. Sherman, (unknown), (unknown), (unknown), Matteo Colombo, Bin Cui, (unknown), Mitsuhiro Kudo, (unknown), Lance A. Roberts, M. Schwartz, Terry M. Therneau, (unknown)	2
15	Sequential Turnover of Human Immunodeficiency Virus Type 1envthroughout the Course of Infection 2006 ·Journal of Virology ·Tara M. Riddle, Norah J. Shire, Marc S. Sherman, (unknown), Haynes W. Sheppard, Julie A. Nelson	13
16	Staging of hepatocellular carcinoma using the clip protocol 2001 ·Journal of Hepatology ·Marc S. Sherman, Izhar Levy, Paul D. Greig, Steve Gallinger, B Langer, Murray Asch, Jason W. Chan	1
17	Calmodulin Target Database 2000 ·Journal of Structural and Functional Genomics ·Kyoko L. Yap, Justin Kim, Kevin Truong, Marc S. Sherman, Tao Yuan, Mitsuhiko Ikura	474
18	Metastatic rhabdomyosarcoma of the heart. 1976 ·PubMed ·Marc S. Sherman, (unknown), L Schamroth	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact